switching from rybelsus to ozempic
Telehealth Physician‑Led Programs Transform GLP‑1 Therapy Choices
Integrating telehealth physician-led programs improves GLP-1 therapy selection, as evidenced by 2023 data showing over 100,000 patients guided through the process. By offering real-time clinician input, these platforms help patients choose between semaglutide, tirzepatide, or Ozempic and keep them on track. Medical Disclaimer: This article is for informational purposes